Back to Search
Start Over
Arcus announces clinical trial collaboration pact to evaluate casdatifan combo
- Source :
- The Fly. October 2, 2024
- Publication Year :
- 2024
-
Abstract
- Arcus Biosciences (RCUS) announced a clinical trial collaboration agreement with AstraZeneca (AZN) to evaluate casdatifan, Arcus's investigational HIF-2a inhibitor, in combination with volrustomig, AstraZeneca's investigational PD-1/CTLA-4 bispecific antibody, in patients [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.810934455